These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 17341535)
41. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. Rosenson RS; Wolff DA; Huskin AL; Helenowski IB; Rademaker AW Diabetes Care; 2007 Aug; 30(8):1945-51. PubMed ID: 17483155 [TBL] [Abstract][Full Text] [Related]
42. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. Bays HE; Maki KC; Doyle RT; Stein E Postgrad Med; 2009 Sep; 121(5):145-50. PubMed ID: 19820283 [TBL] [Abstract][Full Text] [Related]
43. Spontaneous hemothorax following anticoagulation with low-molecular-weight heparin. Ganguli A; Walker L; FitzGerald RJ; Pirmohamed M Ann Pharmacother; 2009 Sep; 43(9):1528-31. PubMed ID: 19690222 [TBL] [Abstract][Full Text] [Related]
44. [Necrotizing myopathy with antilipemic agents. Case report and review of the literature]. Berger O; Zifko U; Jellinger K; Machacek E; Grisold W Nervenarzt; 1993 Aug; 64(8):539-44. PubMed ID: 8413753 [TBL] [Abstract][Full Text] [Related]
46. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709 [TBL] [Abstract][Full Text] [Related]
47. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects. Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303 [TBL] [Abstract][Full Text] [Related]
49. Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate. Steinhoff M; Beyer M; Roewert-Huber J; Lukowsky A; Assaf C; Sterry W J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S88-91. PubMed ID: 18489056 [TBL] [Abstract][Full Text] [Related]
50. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats. Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364 [TBL] [Abstract][Full Text] [Related]
51. Taste and smell disturbance with the alpha-adrenoceptor agonist midodrine. Young TM; Mathias CJ Ann Pharmacother; 2004 Nov; 38(11):1868-70. PubMed ID: 15466905 [TBL] [Abstract][Full Text] [Related]
52. Fenofibrate can increase serum creatinine levels in renal insufficiency. Paul S; Mohan V J Assoc Physicians India; 2006 Apr; 54():337. PubMed ID: 16944623 [No Abstract] [Full Text] [Related]
57. Acute pancreatitis in a patient treated with micafungin. Sato K; Hayashi M; Utsugi M; Ishizuka T; Takagi H; Mori M Clin Ther; 2007 Jul; 29(7):1468-73. PubMed ID: 17825698 [TBL] [Abstract][Full Text] [Related]
58. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study. Carrington M; Stewart S Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072 [TBL] [Abstract][Full Text] [Related]